PlainRecalls
FDA Drug Low Class III Terminated

PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87

Reported: May 17, 2017 Initiated: March 28, 2017 #D-0703-2017

Product Description

PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87

Reason for Recall

Failed Stability Specifications

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
49,089 bottles
Distribution
Nationwide
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87. Recalled by Teva Pharmaceuticals USA. Units affected: 49,089 bottles.
Why was this product recalled?
Failed Stability Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on May 17, 2017. Severity: Low. Recall number: D-0703-2017.